NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
10/24/2023
Back to search
Official data from USPTO
GOFYXII
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
18
Latest update
10/24/2023
Trademark type
Word
Nice classes
5
Filing date
01/30/2023
Registration date
10/24/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/24/2023
Last transaction
10/24/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
4
Owner type
16
Owner location
Marburg, DE
Examiner
NOVAKOVIC, MIROSLAV
Law office
L80
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
CSL Behring GmbH
Representatives
Scott D. Woldow SMITH, GAMBRELL & RUSSELL, LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for treating von Willebrand diseasehemophiliaprimary immunodeficiencyhereditary angioedemafibrinogen deficiencyAlpha 1 antitrypsin deficiencyinflammatory demyelinating polyneuropathy; blood plasma; blood plasma fractions; recombinant protein arrays for medical diagnosis purposes; Pharmaceutical preparations for the treatment and prevention of blood and bleeding disorders; blood products for the treatment of hemophiliapharmaceutical preparations for the treatment of hemophilia; pharmaceutical products derived from recombinant DNA technology for the treatment of hemophiliapharmaceutical preparations derived from recombinant DNA technology for the treatment of hemophilia; blood products for the treatment of hemophiliaa blood clotting aid and delivery system for use in human and veterinary medicine; pharmaceutical preparations and substances for the treatment of blood disorders; antibodiesdiagnostic kits consisting primarily of monoclonal antibodiesbuffersreagents for use in disease testing; blood for medical purposes; cell cultures for medical purposescells for medical or clinical use; cell cultures for medical purposesliving cells for medical use; cell cultures for medical purposesstem cells for medical or veterinary use; pharmaceutical preparations for the treatment of blood conditionsrespiratory conditionspneumoniacovid-19influenza; Pharmaceutical preparationsantibody for the treatment of acute respiratory distress syndromeARDS; pharmaceutical preparationsantibody for the treatment of Idiopathic Pulmonary FibrosisIPF and Interstitial Lung DiseasesILD; Pharmaceutical preparationsantibody for the treatment of Hereditary AngioedemaHAE; Pharmaceutical preparationsfor the treatment of Hereditary AngioedemaHAErespiratory diseasesacute respiratory distress syndromeARDSIdiopathic Pulmonary FibrosisIPF and Interstitial Lung DiseasesILD
Publications
History of USPTO decisions and trademark events.
18 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
10/24/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/08/2023
PUBO
PUBLISHED FOR OPPOSITION
08/08/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/19/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/30/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/30/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/30/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/26/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/23/2023
GNRT
NON-FINAL ACTION E-MAILED
05/23/2023
CNRT
NON-FINAL ACTION WRITTEN
05/23/2023
DOCK
ASSIGNED TO EXAMINER
05/16/2023
PMSG
PETITION TO DIRECTOR - MAKE SPECIAL - GRANTED
05/15/2023
APET
ASSIGNED TO PETITION STAFF
05/15/2023
TPMS
TEAS PETITION TO DIRECTOR-MAKE SPECIAL-RECEIVED
05/08/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/16/2023
NWAP
NEW APPLICATION ENTERED
02/02/2023
Continuous trademark protection
Get notified about every new filing that threatens GOFYXII or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.